Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis

In conclusion, anti-IL-17 monoclonal antibodies are an effective and promising treatment option for HIV-infected patients with psoriasis.Case Rep Dermatol 2020;12:132 –137

https://www.karger.com/Article/FullText/508781

Source: Case Reports in Dermatology - August 12, 2020 Category: Dermatology Source Type: research

More News: Dermatology | Psoriasis | Skin